News

Featured

News

Browse by Publication Year

21 Jul 2026

Nitto Published siRNA Chemical Optimization Research in Nucleic Acid Therapeutics, Advancing Design Strategies for More Durable LNPーMediated Gene Silencing

15 Mar 2026

Nitto Published Antibody-Functionalized LNP Research in Nano Letters, Establishing a Design Principle for Targeted mRNA Delivery.

10 Nov 2025

Nitto Published Bispecific siRNA Research in Molecular Therapy Nucleic Acids, Establishing a Novel Approach for Simultaneous Silencing of Dual Disease Targets

2 Jan 2025

Nitto Published LNP-based Cancer Therapeutics Research in Molecular Cancer Therapeutics, demonstrating the potential of mRNA delivery for cancer treatment

9 Oct 2024

Impact of Lipid Tail Length on the Organ Selectivity of mRNA-Lipid Nanoparticles

9 May 2024

Nitto Published Targeted Delivery Research Using LNPs in Communication Biology, Advancing selective mRNA delivery technologies

Where to Find Us

Events

Sep 2026

RNA Leaders Congress Conference

Sept. 23 – 25, 2026

Hynes Convention Center

Boston, MA
Sep 2026

7th Genome Editing Therapeutics Summit

Sept. 28 - 30, 2026

Hilton Boston Back Bay

Boston, MA
Oct 2026

Cell Gene Meeting on the Mesa

Oct. 5 - 7, 2026

Arizona Biltmore

Phoenix, AZ
Oct 2026

BIO Japan

Oct. 7 – 9, 2026

PACIFICO Yokohama

Yokohama, JP
Oct 2026

European Society of Gene & Cell Therapy (ESGCT)

October 27 - 30, 2026

CCH - Congress Center Hamburg

Hamburg, Germany
Jan 2027

JPM 45th JP Morgan Annual Healthcare Conference 2027

Jan. 11 – 14, 2027

The Westin St. Francis Hotel

San Francisco, CA

Recent Presentations

Abstracts

2023 EORTC NBP 006 Dose Expansion

Download PDF

2023
2023 EORTC Preliminary Dimensions

Learn More

2023
EORTC Combo Study 2023

Learn More

2023
NBF-006 ASCO Final 2023

Learn More

2023

Scientific Resources

Whitepapers

A Novel Lipid Nanoparticle NBF-006 Encapsulating Glutathione S-Transferase P siRNA for the Treatment of KRAS-Driven Non–small Cell Lung Cancer

Non–small cell lung cancer (NSCLC) accounts for approximately 85% of lung cancers,...

Learn More

2024
Drug Delivery Technology: RNA/DNA Lipid Nanoparticle Delivery Platform

Nitto has developed in-house LNP-based RNAi therapeutics for a variety of diseases....

Learn More

2023
Inhibition of GSTP for the Treatment of KRAS-Driven NSCLC using a Novel siRNA Lipid Nanoparticle

Non-small cell lung cancer (NSCLC) accounts for about 85% of all lung...

Learn More

2022